The 2018 Global Gene Expression Analysis Market by Product & Service and End-User - Forecast to 2023 - ResearchAndMarkets.com

The "Gene Expression Analysis Market by Product and Services (Consumables (Reagents, DNA chips), Instruments (PCR, NGS), Services (Gene Expression Profiling)), End User (Pharma and Biotech Companies, Research Centers) - Global Forecasts to 2023" report has been added to ResearchAndMarkets.com's offering.

The global gene expression market is projected to reach USD 4.9 billion by 2023 from USD 3.2 billion in 2018 at a CAGR of 8.8%.

Growth in the gene expression market can be attributed to factors such as the decreasing cost of sequencing, technological advancements, rise in the number of cancer patients, availability of government funding, novel technologies, growing application areas of gene expression, and availability of gene expression databases. However, the high cost of instruments and shortage of trained professionals may prove to be restraints for the market.

The consumables segment is expected to hold the largest market share during the forecast period.

On the basis of products and services, the global gene expression market has been segmented into consumables (reagents, DNA chips), instruments (PCR, NGS, Microarray, others), and services (gene expression profiling services, bioinformatics solutions). The consumables segment is expected to hold the largest market share during the forecast period. The decreasing sequencing costs leading to increased adoption of sequencing and other gene expression analysis techniques are driving growth in this market segment.

The pharmaceutical and biotechnology companies segment is expected to grow at the highest rate during the forecast period.

On the basis of the end user, the gene expression market is segmented into pharmaceutical and biotechnology companies, academic institutes and research centers, and other end users. The pharmaceutical and biotechnology companies segment is expected to grow at the highest rate during the forecast period. The large share and high growth of this segment can be attributed to factors such as high volume of research studies involving gene expression analysis and huge capital for high-end analysis instruments and consumables.

The Asia Pacific gene expression market is expected to grow at the highest rate during the forecast period.

Geographically, the gene expression market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The Asia Pacific market is expected to grow at the highest rate during the forecast period. The high growth in this region can be attributed to domestic manufacturing of sequencing systems, western partnerships to improve healthcare, high R&D intensity, government focus on cancer and other life science research, and flourishing bioresearch centers.

The major players in the market include Thermo Fisher Scientific, Inc. (US), QIAGEN (Netherlands), Illumia (US), PerkinElmer (US), Agilent Technologies (US), GE Healthcare (UK), Bio-Rad Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland), Oxford Gene Technologies (UK), Eurofins Scientific (Luxembourg), and Pacific Biosciences of California (US).

Market Dynamics

Drivers

• Decreasing Cost of Sequencing
• Technological Advancements
• Rising Prevalence of Cancer
• Availability of Government Funding
• Novel Technologies to Aid Gene Expression Studies
• Growing Application Areas of Gene Expression
• Availability of Gene Expression Databases

Restraints

• High Cost of Instruments
• Shortage of Trained Professionals

Opportunities

• Emerging Countries to Provide Growth Opportunities
• Growing Use of Gene Expression Analysis in Precision Medicine

Challenges

• Currency Devaluation

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Market, By Product & Service

7 Market, By End-User

8 Market, By Region

9 Competitive Landscape

10 Company Profiles

• Agilent Technologies
• BGI
• Bio-Rad Laboratories, Inc.
• Eurofins Scientific
• F. Hoffmann-La Roche
• GE Healthcare
• Illumina, Inc.
• Oxford Gene Technology
• Pacific Biosciences of California, Inc.
• Perkinelmer, Inc.
• Qiagen N.V.
• Thermo Fisher Scientific, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/2r63k8/the_2018_global?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181116005310/en/